Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy | Zendy

Aaron A.R. Tobian | Zendy; M. Kate Grabowski | Zendy; David Serwadda | Zendy; Kevin Newell | Zendy; Paschal Ssebbowa | Zendy; Verónica Franco | Zendy; Fred Nalugoda | Zendy; Maria J. Wawer | Zendy; Ronald H. Gray | Zendy; Thomas C. Quinn | Zendy; Steven J. Reynolds | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy

Author(s) -

Aaron A.R. Tobian,

M. Kate Grabowski,

David Serwadda,

Kevin Newell,

Paschal Ssebbowa,

Verónica Franco,

Fred Nalugoda,

Maria J. Wawer,

Ronald H. Gray,

Thomas C. Quinn,

Steven J. Reynolds

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit252

Subject(s) - genital ulcer , viral shedding , herpes simplex virus , medicine , odds ratio , confidence interval , placebo , virology , immunology , virus , sexually transmitted disease , human immunodeficiency virus (hiv) , pathology , alternative medicine , syphilis

The association between initiation of antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection and possible herpes simplex virus type 2 (HSV-2) shedding and genital ulcer disease (GUD) has not been evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research